Coverage
-
April 06, 2021
After the Federal Circuit told the Patent Trial and Appeal Board to take another look at a patent for monitoring information such as blood oxygen level and heart rate, the board has struck down more claims, in a victory for Fitbit Inc.
1 other articles on this case.
View all »